PHARMAXUS
Lifetime
7 annual accounts with figures on one time axisKey points
from the 2025 annual accountsChecked score
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,715 companies had the same profile as PHARMAXUS has now. Each dot stands for 17 companies, two years later.
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,715 companies, not a prediction for PHARMAXUS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| PHARMAXUS Zandhoven | €25,186 | €19,190 | 26.0% | - |
| JL PHARMA Stoumont | €22,608 | €15,096 | 47.5% | - |
| Farmaco Ranst | €17,325 | €22,129 | 5.8% | - |
| DEL PHARMA Mons | €36,943 | €19,174 | 44.1% | - |
| LORENA BOULANGER PHARMA Chapelle-lez-Herlaimont | €32,165 | €14,597 | 80.6% | - |
| Apotheker Silke Christiaens Lennik | €37,111 | €14,322 | 0.0% | - |
| VanbaelenApo Bruges | €39,958 | €19,569 | 46.5% | - |
These companies have the same main activity as PHARMAXUS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €17,300 and €40,000, founded between 2014 and 2020.
Official details
Source: KBO- Status
- Active since 12-04-2018Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730and 2 others
- Establishment unit
- 2.275.649.4942240 Zandhoven, registered on 12-04-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 02-11-2025
Annual accounts 2025
- ≈ €200,000estimated
- €25,186▲ 100%
- Filing
- Filed on 07-07-2026, 24 days before the end of the filing period
Insights on PHARMAXUS
PHARMAXUS files the micro format. That format states no turnover. The gross margin rose from €6,555 in 2019 to €19,190 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about PHARMAXUS
- What is the company number of PHARMAXUS?
- The company number of PHARMAXUS is 0694.693.808. The VAT number is the same number with BE in front: BE 0694.693.808.
- Where is PHARMAXUS based?
- The registered office is at Beemdstraat 2, 2240 Zandhoven.Company details
- What does PHARMAXUS do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of PHARMAXUS?
- PHARMAXUS is a private limited company (BV).
- When was PHARMAXUS founded?
- PHARMAXUS was founded on 12-04-2018.
- Is PHARMAXUS still active?
- Yes, PHARMAXUS is an active enterprise in the KBO register.
- What is the turnover of PHARMAXUS?
- The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €19,190 and 139 comparable companies (NACE 477). It probably lies between €74,000 and €430,000. It is a rough estimate.Financials
- Is PHARMAXUS profitable?
- In financial year 2025, PHARMAXUS made a profit of €13,337.
- Where can I find the annual accounts of PHARMAXUS?
- PHARMAXUS filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARMAXUS due?
- PHARMAXUS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.